Skip to main content

Search Results: keywords:"federal trade commission act"

  • S. 1040 is a bill titled the "Drug Competition Enhancement Act" that aims to modify the Federal Trade Commission Act to prohibit a practice known as "product hopping." Product hopping is when a drug manufacturer makes minor changes to a drug to extend its market exclusivity...

    Simple Explanation

    S. 1040 is a rule that tries to stop medicine makers from making tiny changes to their drugs just to keep other companies from making cheaper versions. It lets a special group check if this is happening and make sure everyone plays fair.

  • S. 4290, also known as the "Antitrust Freedom Act of 2024," proposes changes to United States antitrust laws. It stipulates that the Sherman Act, the Clayton Act, and certain sections of the Federal Trade Commission Act should not be interpreted to prohibit voluntary economic...

    Simple Explanation

    S. 4290 wants to let people and groups make deals together without worrying about breaking some big rules that stop businesses from getting too big and unfair, but some people think this could let bad behaviors, like making everything cost too much, happen too easily.

  • S. 150 aims to modify the Federal Trade Commission Act to stop product hopping. The bill introduces changes to patent laws concerning biological products, restricting the number of patents that can be asserted in infringement cases and specifying conditions under which courts...

    Simple Explanation

    S. 150 is like a rule that tries to stop companies from sneaking around with medicine products, and it also gives a lot of money to help make a health program called Medicare better.

  • H.R. 9452, titled the “Common Sense Real Estate Consumer Rights Protection Act of 2024,” seeks to provide antitrust exemptions for state-licensed real estate brokers, their salespersons, and any trade associations they might belong to. It emphasizes that the regulation and...

    Simple Explanation

    This bill wants to let real estate agents and their groups have their own special rules so they don't always have to follow big national rules. It believes that each state should be able to make its own rules about selling houses and buildings.

  • S. 1040 aims to alter the Federal Trade Commission Act to stop pharmaceutical companies from engaging in "product hopping." This practice involves making minor changes to a drug, like reformulating it, to extend patent protections and delay generic versions from entering the...

    Simple Explanation

    S. 1040 is a proposed law that wants to stop medicine companies from slightly changing their medicines just to keep other companies from making less expensive versions. It tells the rules so everyone plays fair and doesn’t cheat by removing old medicines to make people buy new ones.